STAT

Justice for Jane Doe: A New York attorney becomes the face of a crucial abortion rights case

ACLU attorney Brigitte Amiri is at the center of a case seeking to overturn the Trump administration's policy preventing abortions for unaccompanied immigrant teens in federal custody.

NEW YORK — Brigitte Amiri, an attorney with the American Civil Liberties Union, was spending the weekend on Long Island with her family in late September when she got the call about Jane Doe.

She wasn’t Jane Doe just yet. She was a pregnant 17-year-old immigrant from Central America being held in federal custody after entering the U.S. illegally. She’d obtained a judge’s permission to get an abortion. But the Office of Refugee Resettlement — a branch of the Trump administration responsible for unaccompanied immigrant minors — wouldn’t allow it.

It required Jane Doe to visit a “crisis pregnancy center,” where she has said staff tried to discourage her from having an abortion and prayed for her. When she persisted, ORR blocked her from traveling to an abortion clinic.

Her advocates with Jane’s Due Process in Texas knew whom to call for help — Amiri, a tireless, quick-thinking lawyer with a reputation as a fierce champion of women battling government restrictions on abortion and access to contraception.

“Ever since I was little, I had a streak in me that fought back against what was unfair, particularly when it came to girls being treated differently than boys,” she told STAT.

As an attorney at the ACLU’s Reproductive Freedom Project, she has a South Dakota law requiring women to visit a crisis pregnancy center before obtaining an abortion and an Alaska restricting Medicaid funding for abortion. She has sued the Obama administration over abortion and contraception access for immigrant teens. And she has played

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks